Thomas Frank E

AMAG Pharmaceuticals, Inc.

President & COO

Avg. Two Year Performance

26% Avg. Purchase Return 12% Compound

52% Avg. Sale Return 23% Compound

Holdings: 138.19K shares

Last Three Months: 17-Feb-24 -- 16-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

17-May-22 -- 16-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions